Chi Udeh-Momoh, MSc, PhD, FHEA
We can reduce the scale and impact of dementia via multidisciplinary collaborative approaches towards equitable, accessible brain health promotion strategies aimed at prevention or improved quality of life outcomes for those living with dementia.
Chi is a Senior Researcher and Biomarker and Programme Lead providing scientific management of several neurodegenerative disease research studies undertaken by the Ageing Epidemiology research unit at Imperial College, a Senior Scientist at Karolinska Institute and a Principal Investigator for the HPADEMPREV and FINGER-AFRICA programmes.
Nothing is impossible for God!
Words of Strength
Innovative, Building relationships, Enthusiastic, Collaborative
The scale and impact of dementia may be reduced via multidisciplinary collaborative approaches towards equitable, accessible brain health promotion strategies aimed at prevention or improved quality of life outcomes for those living with dementia.
As part of World Wide FINGERS - a global interdisciplinary network – Chi is developing a culturally sensitive, sustainable, multi-domain lifestyle dementia prevention strategy, expected to increase biomarker-access for prediction and diagnosis, reduce multi-morbidity and improve health outcomes.
As an Atlantic Fellow, Chi hopes to address significant gaps in biomarker/health-access inequalities in some of the world’s poorest regions via strategic biomarker-enriched Alzheimer's disease prevention studies in Africa that can be applied to other low-income-countries.
Dementia prevalence in Sub-Saharan-Africa (SSA) is expected to increase up to 2000% by 2050. With incidence linked to presence of modifiable risk factors, brain health promotion strategies offer a promising solution for dementia risk-reduction here.
Dr Chi Udeh-Momoh is a Translational Neuroscientist with affiliations at Imperial College London, Karolinska Institute and Bristol University. Having completed a competitive CASE PhD studentship in Neuroscience and Neuroendocrinology at the MRC Centre for Synaptic Plasticity at the University of Bristol (2010-2014), her current research focuses on dementia prevention bio-mechanistic pathways and strategies, also across diverse populations. In 2018, she founded the FINGER-AFRICA project that aims to promote brain health and mitigate biomarker-access inequalities through culturally-sensitive sustainable multimodal intervention strategies in Sub-Saharan African populations, and identify related molecular mechanisms contributing to observed effects. She is co-Lead of the World-Wide FINGERS Biomarker Consortium, and on the Executive committee for the Biofluids-biomarker-based PIA of the Alzheimer’s Association ISTAART (2018 - present). She is also co-Founder of the Female Brain and Endocrine Research consortium (FEMBER). Chi leads multinational initiatives to address gender and racial disparities in medical research and academia, as part of the Opportunity Committee at Imperial College, and further sits on the Board of Trustees of the British Society for Neuroendocrinology as the Equality and Diversity Inclusion Lead.